Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

4 February 2024

Salaheldin AhmedAbdulla AhmedGöran Rådegran 

https://doi.org/10.1002/pul2.12340

Abstract

To the editor, 

Pulmonary hypertension (PH) is a common condition, present in up to 10% in individuals aged >65 years.1 Whitin this entity, pulmonary arterial hypertension (PAH; group I PH) and chronic thromboembolic pulmonary hypertension (CTEPH; group 4 PH) comprise two rare, but detrimental conditions characterized by pulmonary vasculopathies and remodeling of pulmonary arteries, leading ultimately to right heart failure and death.2 These conditions are accompanied by high morbidity and mortality, for which early diagnosis and treatment initiation are paramount to improve outcome.3

Read the full letter to the editor

Share:
Additional comments are available to members. Login or register to become a member today